Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said.
Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals. P. aeruginosa infections are generally limited to hospital settings.
The recall affects various products with the Lot# 001005-1 Best by: 04/2023 & LiviaOne Nasal Probiotics with Lot# 010620-1 Best by 08/2023.
LiviaOne Daily Probiotics 2oz and 4oz, LiviaOne Topical Spray Probiotics 4oz, LiviaOne Nasal Probiotics 1oz, BioLifePet Probiotics for Cats and BioLifePet Probiotics for Dogs have been called back.
These products were distributed nationwide through Amazon, wholesale, and direct sales from the company's website.
The recall was initiated after the company discovered the potential issue during routine 3rd party laboratory testing, which is part of Livia Global's quality assurance procedures and safety protocols.
However, the company has not received a direct complaint from using their products.
Impacted consumers are urged to contact Livia Global Customer Care to request a full refund.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.